Analyst Ratings For ConforMIS Inc (NASDAQ:CFMS)
Today, Oppenheimer reiterated its Buy rating on ConforMIS Inc (NASDAQ:CFMS).
There are 5 Buy Ratings, 1 Sell Ratings, no Strong Buy Ratings, no Hold Ratings on the stock.
The current consensus rating on ConforMIS Inc (NASDAQ:CFMS) is Buy with a consensus target price of $3.75 per share, a potential 192.97% upside.
Some recent analyst ratings include
- 9/18/2018-ConforMIS Inc (NASDAQ:CFMS) had its Buy rating reiterated by Oppenheimer
- 8/2/2018-ConforMIS Inc (NASDAQ:CFMS) had its Buy rating reiterated by BTIG Research with a $3.00 price target
- 7/16/2018-ConforMIS Inc (NASDAQ:CFMS) had its Buy rating reiterated by SunTrust Banks
- 4/10/2018-ConforMIS Inc (NASDAQ:CFMS) gets upgraded to Buy by Canaccord Genuity with a price target of $4.00
- 2/21/2018-ConforMIS Inc (NASDAQ:CFMS) has coverage initiated with a Outperform rating and $4.00 price target
- 1/2/2018-ConforMIS Inc (NASDAQ:CFMS) gets downgraded to Underweight by JPMorgan Chase & Co.
- 8/4/2017-ConforMIS Inc (NASDAQ:CFMS) had its Buy ➝ Hold rating reiterated by Deutsche Bank with a $5.00 price target
Recent Insider Trading Activity For ConforMIS Inc (NASDAQ:CFMS)
ConforMIS Inc (NASDAQ:CFMS) has insider ownership of 7.59% and institutional ownership of 40.13%.
- On 8/8/2018 Daniel Steines, CTO, sold 1,542 with an average share price of $0.91 per share and the total transaction amounting to $1,403.22.
- On 8/8/2018 Mark A Augusti, CEO, sold 7,618 with an average share price of $0.91 per share and the total transaction amounting to $6,932.38.
- On 8/8/2018 Paul S Weiner, CFO, sold 2,529 with an average share price of $0.91 per share and the total transaction amounting to $2,301.39.
- On 5/16/2018 Daniel Steines, Insider, sold 3,480 with an average share price of $1.30 per share and the total transaction amounting to $4,524.00.
- On 5/16/2018 Mark A Augusti, CEO, sold 7,638 with an average share price of $1.30 per share and the total transaction amounting to $9,929.40.
- On 5/16/2018 Paul S Weiner, CFO, sold 3,711 with an average share price of $1.30 per share and the total transaction amounting to $4,824.30.
- On 5/2/2018 Bradley Langdale, Director, sold 9,465 with an average share price of $1.35 per share and the total transaction amounting to $12,777.75.
About ConforMIS Inc (NASDAQ:CFMS)
ConforMIS, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides ConforMIS Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, and Monaco. ConforMIS, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.
Recent Trading Activity for ConforMIS Inc (NASDAQ:CFMS)
Shares of ConforMIS Inc closed the previous trading session at 1.28 up +0.17 15.32% with shares trading hands.